Scale up fermentation and isolation of medinamycin
Ended Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $554,127
Award facts
- Contract value 100% obligated
- $554,127.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $554,127 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $554,127.00 Cost Plus Fixed Fee contract to Curia Global Inc., doing business as Amri, for the "SCALE UP FERMENTATION AND ISOLATION OF MEDINAMYCIN" effort. This is a Delivery Order issued under the Nonclinical Services for Development of Interventional Agents indefinite-delivery, indefinite-quantity (IDIQ) contract. Curia Global is a leading global contract development and manufacturing organization (CDMO) that has supported numerous federal agencies, primarily the National Institutes of Health (NIH) and its institutes, through prime and subcontract awards for various pharmaceutical research and development services. This contract does not have a set-aside designation. The work will be performed in Albany, New York and is scheduled for completion by September 30, 2024.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to Curia Global Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 3, 2022.
How much is contract 75N93022F00001 worth?
The government has obligated $554,127 on 75N93022F00001.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93018D00008, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award